The Era of At-Home Cosmetic Injections is Here! Report on the 'CONC LABO Hyalo-Cica Rich Shot' Launch Event

Euglena Co., Ltd. (Headquarters: Minato-ku, Tokyo; President: Mitsuru Izumo; hereinafter "Euglena") held a media briefing to introduce its new targeted serum, 'CONC LABO Hyalo-Cica Rich Shot,' which aims to provide both moisture and firmness for skin prone to dryness and instability. The product is scheduled for release on Monday, March 16, 2026. This is a report on the event. CONC Hyalo-Cica Rich Shot

Addressing concerns such as loss of firmness and elasticity, as well as dryness and skin instability that become more prominent with age, Takashi Ando, Senior Brand Manager at Euglena, introduced this product as a solution that achieves both 'offensive' anti-aging care and 'defensive' care. He presented the new skincare concept of an 'injectable serum' and explained the approach combining Hyaluronic Acid*3 and CICA extract*4 (Centella Asiatica extract).

Takashi Ando, Senior Brand Manager, Cosmetics Planning and Development Department, Euglena Co., Ltd. Joined Euglena Co., Ltd. in 2006 and participated as a launch manager for the healthcare business. Following the company's listing on the Tokyo Stock Exchange Mothers (now Tokyo Stock Exchange Growth Market) in 2012, he was involved in launching the company's own cosmetics brand business. He became the Brand Manager for the CONC brand in 2021 and has been in his current position since 2023. He is committed to creating new beauty value centered on open-innovation development that leverages the company's strengths as a biotechnology venture.

Excerpt from the presentation slides

From 'Applying' to 'Piercing.' What is the new approach proposed by CONC? Ando: "The 'CONC LABO' series is a function-specialized brand based on the concept of 'translating medical inspiration into daily skincare.' As the demand for cosmetic medicine grows, we are offering a full-scale..."